CDH13 and urinary bladder carcinoma: The OR value of CDH13 methylation in bladder cancer patients compared with non-tumor controls was 21.71 (95 % CI: 9.83–47.94, P < 0.001) (Fig. 2); this analysis included 920 bladder cancer patients and 265 controls.